In their joint declaration, the leaders stressed on strengthening primary healthcare, health workforce and essential health services to better-than-pre-pandemic levels, ideally within the next two to three years.
Besides focusing on epidemics such as tuberculosis and AIDS, the grouping of emerging and developed economies recognised the importance of research on long COVID-19.
The G20 leaders committed to improve access to medical countermeasures and facilitate more supplies and production capacities in developing countries to prepare better for future health emergencies.
The G20 New Delhi Leaders' Declaration highlighted the need to promote the One Health-based approach driven by the quadripartite One Health Joint Plan of Action (2022-2026) and enhance the resilience of health systems.
It also stressed the need to support development of climate-resilient and low-carbon health systems in collaboration with multilateral development bank (MDBs), and support the work of the WHO-led Alliance for Transformative Action on Climate and Health (ATACH).
It also stressed on implementing and prioritising tackling antimicrobial resistance (AMR) following the One Health approach, including through research and development, infection prevention and control, as well as antimicrobial stewardship efforts within respective national action plans through AMR and antimicrobial consumption surveillance.
The Declaration called for facilitating equitable access to safe, effective, quality-assured, and affordable vaccines, therapeutics, diagnostics, and other medical countermeasures, especially in low-and middle-income countries and least developed countries.
The declaration recognised the potential role of evidence-based traditional and